• Mashup Score: 3

    November 2021 Diabetes Care ADA REMIT-SITA: Remission of type 2 diabetes following a short-term intensive intervention with insulin glargine, sitagliptin, and metformin: results of an open-label randomized parallel-design trial N McInnes, S Hall, I Hramiak, RJ Sigal, R Goldenberg, N Gupta, R…

    Tweet Tweets with this article
    • RT @PHRIresearch: đź“šWeekly update: Recent Publications by #PHRI Researchers (just a few of them) https://t.co/PjyKR0afBC @CircHF #PACThf #HF…

  • Mashup Score: 1

    COMPLETE: Revascularization in patients undergoing a pharmacoinvasive strategy for ST-segment–elevation myocardial infarction – insights from the trial Circulation: Cardiovascular Interventions P Dehghani, WJ Cantor, J Wang, DA Wood, RF Storey, R Mehran, KR Bainey, RC Welsh, J Rodes-Cabau, S Rao, S Lavi, JL Velianou, MK Natarajan, A Ziakas, V Guiducci, F Fernandez-Aviles, JA Cairns, SR…

    Tweet Tweets with this article
    • RT @PHRIresearch: Keeping on top of all the #PHRI studies published is no easy task!.. Read the latest at: https://t.co/nOrMkgG1E2 @CircInt…

  • Mashup Score: 2

    Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes The New England Journal of Medicine HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, RD Lopes, CSP Lam, NS Khurmi, L Heenan, S Del Prato, L Dyal, K Branch June 2021 Read More COMPASS: Low-dose rivaroxaban plus aspirin in patients with…

    Tweet Tweets with this article
    • RT @PHRIresearch: Hot off the presses... Recent publications by #PHRI researchers! https://t.co/yEKGFc8bES @NEJM #efpeglenatide #type2diabe…